Biocon Limited (which holds around 78 per cent) will acquire the remaining stake in Biocon Biologics through a share swap…
Discover Nuvama’s top 7 pharma stock picks with up to 33% upside; check out the latest targets and opportunities now.
SBI Mutual Fund has purchased 3,70,150 shares of Biocon.
India’s API market, valued at US$14.2 billion in 2025, is racing ahead at 8.5% CAGR, and 3 pharma stocks are…
Stocks to watch today, September 19: GIFT Nifty indicates a lower start for domestic indices. Here are the top stocks…
Stocks to watch today, September 18: GIFT Nifty indicates a higher start for domestic indices. Here are the top stocks…
Stocks to watch today, September 05: GIFT Nifty indicates a higher start for domestic indices. Here are the top stocks…
Track IndiGo, TCS, Oil India, BPCL, and more as major developments and investments put these 7 stocks in focus- see…
India’s biotech industry is projected to more than double to US$ 300B by 2030. And the ‘smart money’ is making…
Karnataka CM Siddaramaiah and Biocon chief Kiran Mazumdar-Shaw have been up in arms against each other over the heated debate…
Biocon Biologics, a subsidiary of Biocon, has secured EU marketing authorisation for its Denosumab biosimilars Vevzuo and Evfraxy, expanding treatment…
The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other emerging markets, Bloomberg…
Biocon Biologics secures Health Canada approval for Yesafili, the first biosimilar to Eylea® in Canada, with a global launch scheduled…
Biocon Biologics collaborates with Malaysia’s National Cancer Society to launch a Patient Assistance Program, providing affordable biosimilars like Trastuzumab to…
Discover 10 key stocks to watch today, including HDFC Bank’s IPO and Nestle India’s bonus issue. Check updates to inform…
Stocks to watch today, June 17: GIFT Nifty indicates a flat start for domestic indices. Here are top stocks to…
Watch top stocks today: Grasim, HCL, Biocon and more as they make key moves and announcements. Explore the detailed insights…
Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to grow…